Prostate cancer cell

Li Y, Hong X, Hussain M, Sarkar SH, Li R, Sarkar FH. Gene expression profiling revealed novel molecular targets of docetaxel and estramustine combination treatment in prostate cancer cells. Mol Cancer Ther 2005 4 389-98. 

Zhang JM, An J (2007) Cytokines, inflammation, and pain. Int Anesthesiol Clin 45 27-37 Zhang RX, Liu B, Wang L, Ren K, Qiao JT, Berman BM, Lao L (2005) Spinal ghal activation in a new rat model of bone cancer pain produced by prostate cancer cell inoculation of the tibia. Pain 118 125-136... 

CHIAO J W, CHUNG F, KRZEMINSKI J, AMIN S, ARSHAD R, AHMED, T aud CONAWAY C C (2000) Modulation of growth of human prostate cancer cells hy the N- acetylcysteine conjugate of pheuethyl isothiocyanate , Int J Oncol, 16 1215-9. 

PASCHKA A G, BUTLER R and YOUNG c Y (1998) luductiou of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate . Cancer Lett, 130, 1-7. 

PETERSON G and BARNES s (1993) Genistein and hiochanin A inhibit the growth of hiunan prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation. Prostate. 22 (4) 335-45. 

Cha, T.L. et al., Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth, Cancer Res., 65, 2287, 2005. 

In the NF-kB pathway with celastrol 76, the inhibition of the iKBa degradation is due to the upstream blockage of the kinase activity and not by the direct inhibition of proteasome activity. On the contrary, direct inhibition of proteasome activity was observed with celastrol 76 and pristimerin 2 in prostate cancer cells.90-92 Both triterpene QMs directly inhibited the activity of the 20S subunits of proteasome at 2.5 iM and induced the accumulation of ubiquitinated proteins over time in cells,... 

Moore BB, Arenberg DA, Stoy K, et al. Distinct CXC chemokines mediate tumori-genicity of prostate cancer cells. Am J Pathol 1999 154(5) 1503-1512. 

Singh S, Singh UP, Stiles JK, Grizzle WE, Lillard JW Jr. Expression and functional role of CCR9 in prostate cancer cell migration and invasion. Clin Cancer Res 2004 10 8743-8750. 

Jarry H, Thelen P, Christoffel V, Spengler B, Wuttke W. Cimicifuga racemosa extract BNO 1055 inhibits proliferation of the human prostate cancer cell line LNCaP. Phytomedicine 2005 12 178-182. 

Kotake-Nara, E, Kim, SJ, Kobori, M, Miyashita, K, and Nagao, A, 2002. Acyclo-retinoic acid induces apoptosis in human prostate cancer cells. Anticancer Res 22, 689-695. 

Hantz, H. L., L. F. Young, and K. R. Martin. 2005. Physiologically attainable concentrations of lycopene induce mitochondrial apoptosis in LNCaP human prostate cancer cells. Exp Biol Med (Maywood) 230(3) 171-179. 

Hwang, E. S. and P. E. Bowen. 2004. Cell cycle arrest and induction of apoptosis by lycopene in LNCaP human prostate cancer cells. J Med Food 7(3) 284-289. 

Kotake-Nara, E., M. Kushiro, H. Zhang et al. 2001. Carotenoids affect proliferation of human prostate cancer cells. JNutr 131(12) 3303-3306. 

Another focus has been on the invasiveness of prostate cancer cells since prostate cancer lethality is tied to metastatic processes. Metastatic cells have acquired the ability to invade basement... 

Forbes, K, K Gillette, and I Sehgal. 2003. Lycopene increases urokinase receptor and fails to inhibit growth or connexin expression in a metastatically passaged prostate cancer cell line a brief communication. Exp Biol Med 228 967-971. 

Gitenay, D, B Lyan, J Talvas, A Mazur, S George, C Caris-Veyrat, and E Rock. 2007. Serum from rats fed red or yellow tomatoes induced Connexin-43 expression independently from lycopene in a prostate cancer cell line. Biochem Biophys Res Commun 364 578-582. 

Hwang, E-S and PE Bowen. 2005b. Effects of tomato paste extracts on cell proliferation, cell-cycle arrest and apoptosis in LNCaP human prostate cancer cells. Biofactors 23 75-84. 

Kanagaraj, P, MR Vijayababu, B Ravisankar, J Anbalagan, MM Aruldhas, and J Aranakaran. 2007. Effect of lycopene on insulin-like growth factor-1, IGF binding protein-3, and IGF type-1 receptor in prostate cancer cells. 7 Cancer Res Clin Oncol 133 351-359. 

---